Cambridge Bioscience Named Exclusive Distributor for NanoInk in UK, Ireland | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoInk today announced that Cambridge Bioscience will exclusively distribute its desktop nanofabrication equipment in the UK and Ireland.

The deal includes NanoInk's NLP 2000 System and DPN 5000 System.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.